12 unchanged sentences
Rule 10b5-1 Trading Plans.
−Removed: During 2024, none of UTMD’s directors or executive officers adopted Rule 10b5-1, and none of UTMD’s directors or executive officers terminated a Rule 10b5-1 trading plan or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
+Added: During 2025, none of UTMD’s directors or executive officers adopted a Rule 10b5-1 trading plan, and none of UTMD’s directors or executive officers terminated a Rule 10b5-1 trading plan or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
ITEM 9C – DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
55 unchanged sentences
Incorporated by Reference (5)
−Removed: Summary of Officer and Director Compensation
Insider Trading Policy
+Added: Incorporated by Reference (6)
Subsidiaries of Utah Medical Products, Inc.
8 unchanged sentences
Policy Relating to Recovery of Erroneously Awarded Compensation
−Removed: Title of Document
+Added: Incorporated by Reference (6)
XBRL Instance Document
10 unchanged sentences
(5) Incorporated by reference from the Company’s report on form S-8 filed with the Commission on July 14, 2023.
+Added: (6) Incorporated by reference from the Company’s annual report on form 10-K filed with the Commission for the year ended December 31, 2024.
ITEM 16 – FORM 10-K SUMMARY
6 unchanged sentences
Hoyer, Director
−Removed: /s/ Barbara A.
−Removed: Payne, Director
Richins, Director
1 unchanged sentence
Carrie Leigh, Director
+Added: /s/ Kevin Timken
+Added: Kevin Timken, Director
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.